| scholarly article | Q13442814 |
| P2093 | author name string | Yutaka Kondo | |
| P2860 | cites work | Identification and characterization of a family of mammalian methyl-CpG binding proteins | Q22003967 |
| DNA methylation patterns and epigenetic memory | Q22065780 | ||
| Translating the Histone Code | Q22065840 | ||
| Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 | ||
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans | Q24304064 | ||
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation | Q24338119 | ||
| Genome-wide maps of chromatin state in pluripotent and lineage-committed cells | Q24632506 | ||
| DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA | Q24645346 | ||
| Worms gang up on bacteria | Q27860588 | ||
| The language of covalent histone modifications | Q27860931 | ||
| A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 | ||
| Role of histone H3 lysine 27 methylation in Polycomb-group silencing | Q28131795 | ||
| Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation | Q28139187 | ||
| Signaling to chromatin through histone modifications | Q28142598 | ||
| The epigenomics of cancer | Q28289975 | ||
| The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation | Q28304726 | ||
| G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription | Q28513698 | ||
| The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA | Q28589108 | ||
| A chromatin landmark and transcription initiation at most promoters in human cells | Q29547180 | ||
| Dissecting direct reprogramming through integrative genomic analysis | Q29614211 | ||
| In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state | Q29614212 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| New nomenclature for chromatin-modifying enzymes | Q29616425 | ||
| Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome | Q29616819 | ||
| Methylation-induced repression--belts, braces, and chromatin | Q29617487 | ||
| Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome | Q29618064 | ||
| Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines | Q29620526 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| The establishment and maintenance of DNA methylation patterns in mouse somatic cells | Q33765663 | ||
| The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. | Q33781484 | ||
| Stabilization of chromatin structure by PRC1, a Polycomb complex | Q33868583 | ||
| Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation | Q33905462 | ||
| G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. | Q34485045 | ||
| Epigenetic changes in colorectal cancer. | Q35682096 | ||
| The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. | Q35804605 | ||
| Epigenetic therapy of cancer: past, present and future | Q36399557 | ||
| Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line | Q36861718 | ||
| De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes | Q36968883 | ||
| A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation | Q37122031 | ||
| DNA methylation dictates histone H3K4 methylation | Q40180250 | ||
| Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state | Q40296469 | ||
| CpG islands and genes | Q40406688 | ||
| DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. | Q40907825 | ||
| Histone acetylation and chromatin assembly: a single escort, multiple dances? | Q41152817 | ||
| Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells | Q41460436 | ||
| Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation | Q42239046 | ||
| A histone H3 methyltransferase controls DNA methylation in Neurospora crassa | Q42664087 | ||
| DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity | Q43251760 | ||
| Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation | Q44364520 | ||
| Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. | Q45950089 | ||
| Protein demethylation required for DNA methylation | Q46372163 | ||
| Polycomb silencing blocks transcription initiation. | Q47850992 | ||
| The histone tails of the nucleosome | Q48018656 | ||
| Dynamic regulation of histone H3 methylation at lysine 4 in mammalian spermatogenesis | Q53540526 | ||
| Histone lysine demethylases and their impact on epigenetics | Q53626346 | ||
| CpG islands in mammalian gene promoters are inherently resistant to de novo methylation | Q54273353 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors | Q74181079 | ||
| Decitabine | Q79303700 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | histone | Q36293 |
| histone methyltransferase | Q2560317 | ||
| DNA methylation | Q874745 | ||
| neoplasm | Q1216998 | ||
| genetic epigenesis | Q64443099 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 455-463 | |
| P577 | publication date | 2009-08-19 | |
| 2009-08-31 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Yonsei Medical Journal | Q8055114 |
| P1476 | title | Epigenetic cross-talk between DNA methylation and histone modifications in human cancers | |
| P478 | volume | 50 |
| Q37389377 | A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells |
| Q34064494 | An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers |
| Q35765192 | Association of aberrant DNA methylation in Apc(min/+) mice with the epithelial-mesenchymal transition and Wnt/β-catenin pathways: genome-wide analysis using MeDIP-seq |
| Q41056167 | BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer |
| Q41751900 | Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma |
| Q39431594 | Cross‐talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL |
| Q41534142 | DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression |
| Q91708347 | DNA Methylation Cancer Biomarkers: Translation to the Clinic |
| Q92068538 | DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses |
| Q89136390 | DNMT1 modulates interneuron morphology by regulating Pak6 expression through crosstalk with histone modifications |
| Q57788769 | DNMTs inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells |
| Q34103976 | Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon. |
| Q50014666 | Dietary Modulation of the Epigenome |
| Q33769472 | Discovering cooperative relationships of chromatin modifications in human T cells based on a proposed closeness measure |
| Q39612445 | EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo |
| Q33992088 | Early-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness |
| Q90354133 | Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer |
| Q45723813 | Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis |
| Q28385993 | Environmental epigenetics and its implication on disease risk and health outcomes |
| Q28388771 | Environmental epigenetics of asthma: An update |
| Q39392105 | Epigenetic Histone Modification of Epstein-Barr Virus BZLF1 Promoter during Latency and Reactivation in Raji Cells |
| Q98288873 | Epigenetic Modifications due to Environment, Ageing, Nutrition, and Endocrine Disrupting Chemicals and Their Effects on the Endocrine System |
| Q36080974 | Epigenetic biomarkers in skin cancer |
| Q38098179 | Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency |
| Q33679242 | Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories |
| Q28084220 | Epigenetic regulation of Keap1-Nrf2 signaling |
| Q47356836 | Epigenetic regulation of protein glycosylation |
| Q37822876 | Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2 |
| Q37626242 | Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages |
| Q39009379 | Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives |
| Q38019955 | Epigenetics and blood disorders |
| Q34085532 | Epigenetics and cancer |
| Q33810295 | Epigenetics meets endocrinology |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q90370608 | Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance |
| Q47549184 | Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. |
| Q24611593 | Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines |
| Q35032951 | Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer |
| Q37083880 | Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors. |
| Q36345181 | Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression |
| Q42496397 | H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes |
| Q96302740 | Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner |
| Q38694866 | Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy. |
| Q55006760 | In silico modeling of epigenetic-induced changes in photoreceptor cis-regulatory elements. |
| Q37974887 | Inflammation, DNA methylation and colitis-associated cancer |
| Q26781968 | Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases |
| Q61814607 | Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy |
| Q90477163 | JAK2 regulates mismatch repair protein-mediated epigenetic alterations in response to oxidative damage |
| Q35878156 | LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system |
| Q24319083 | Location-Specific Epigenetic Regulation of the Metallothionein 3 Gene in Esophageal Adenocarcinomas |
| Q97520866 | Modern epigenetics methods in biological research |
| Q37529397 | Oestrogen receptor negativity in breast cancer: a cause or consequence? |
| Q38018996 | Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation |
| Q38271076 | Prostate cancer epigenome |
| Q37064586 | Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines |
| Q86671475 | Reasons of carcinogenesis indicate a big-bang inside: A hypothesis for the aberration of DNA methylation |
| Q39007485 | Regulation of MDA-MB-231 cell proliferation by GSK-3β involves epigenetic modifications under high glucose conditions |
| Q34766981 | SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells |
| Q38890886 | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells |
| Q47597906 | Sexually Dimorphic Epigenetic Regulation of Brain-Derived Neurotrophic Factor in Fetal Brain in the Valproic Acid Model of Autism Spectrum Disorder. |
| Q34654640 | Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer |
| Q47103199 | The Effect of Vitrification on Expression and Histone Marks of Igf2 and Oct4 in Blastocysts Cultured from Two-Cell Mouse Embryos |
| Q97544025 | The Histone Lysine-specific Demethylase 1 Inhibitor, SP2509 Exerts Cytotoxic Effects against Renal Cancer Cells through Downregulation of Bcl-2 and Mcl-1 |
| Q34692752 | The biology of lysine acetylation integrates transcriptional programming and metabolism |
| Q37903980 | The potential role of epigenetic responses to diet in ageing |
| Q37295496 | The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells |
| Q39197389 | The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells |
| Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
| Q90295602 | The significance of the placental genome and methylome in fetal and maternal health |
| Q64075945 | Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms |
| Q38215923 | Toxicogenomics and cancer susceptibility: advances with next-generation sequencing. |
| Q37122127 | Visualization of multivalent histone modification in a single cell reveals highly concerted epigenetic changes on differentiation of embryonic stem cells |
| Q36184617 | Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells. |
Search more.